Nifty
Sensex
:
:
21915.35
72209.86
-80.50 (-0.37%)
-279.13 (-0.39%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 531823 | NSE: ARVINDREM

Not traded in the last 30 days
  • Open
  • High
  • Low
  • Previous Close
  •  N/A
  •  N/A
  •  N/A
  •  N/A
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  N/A
  •  N/A
  •  N/A
  •  N/A

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 32.02
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 778.29
  • N/A
  • N/A

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 3.58%
  • 10.48%
  • 79.19%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 6.75%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
-
962.68
706.12
467.73
362.55
Net Sales Growth
-
36.33%
50.97%
29.01%
 
Cost Of Goods Sold
-
664.99
489.52
345.99
287.92
Gross Profit
-
297.70
216.60
121.74
74.64
GP Margin
-
30.92%
30.67%
26.03%
20.59%
Total Expenditure
-
781.32
565.62
395.24
321.31
Power & Fuel Cost
-
4.68
3.96
1.67
0.57
% Of Sales
-
0.49%
0.56%
0.36%
0.16%
Employee Cost
-
20.31
15.65
10.61
6.65
% Of Sales
-
2.11%
2.22%
2.27%
1.83%
Manufacturing Exp.
-
71.19
40.45
25.84
18.00
% Of Sales
-
7.39%
5.73%
5.52%
4.96%
General & Admin Exp.
-
7.99
6.72
4.73
3.10
% Of Sales
-
0.83%
0.95%
1.01%
0.86%
Selling & Distn. Exp.
-
6.55
4.54
2.73
1.91
% Of Sales
-
0.68%
0.64%
0.58%
0.53%
Miscellaneous Exp.
-
5.63
4.79
3.67
3.15
% Of Sales
-
0.58%
0.68%
0.78%
0.87%
EBITDA
-
181.36
140.50
72.49
41.24
EBITDA Margin
-
18.84%
19.90%
15.50%
11.37%
Other Income
-
0.54
0.78
0.58
0.34
Interest
-
78.51
60.30
28.96
16.39
Depreciation
-
14.34
12.98
3.84
2.43
PBT
-
89.05
68.00
40.26
22.77
Tax
-
28.69
23.04
18.57
5.87
Tax Rate
-
32.22%
33.88%
46.13%
25.78%
PAT
-
58.49
43.39
20.87
16.90
PAT before Minority Interest
-
60.36
44.96
21.70
16.90
Minority Interest
-
-1.87
-1.57
-0.83
0.00
PAT Margin
-
6.08%
6.14%
4.46%
4.66%
PAT Growth
-
34.80%
107.91%
23.49%
 
EPS
-
8.59
6.37
3.06
2.48

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
283.06
198.24
144.29
121.61
Share Capital
68.13
48.23
48.23
48.23
Total Reserves
214.92
133.84
96.06
73.38
Non-Current Liabilities
288.00
321.01
214.33
91.79
Secured Loans
244.86
279.65
189.48
79.44
Unsecured Loans
0.00
0.00
0.00
0.00
Long Term Provisions
0.52
0.36
0.23
0.22
Current Liabilities
547.46
344.35
267.70
156.52
Trade Payables
97.05
71.75
49.08
40.82
Other Current Liabilities
81.94
40.04
49.40
10.58
Short Term Borrowings
346.29
223.70
161.65
100.88
Short Term Provisions
22.18
8.86
7.57
4.24
Total Liabilities
1,123.37
866.58
627.73
369.92
Net Block
356.65
258.04
249.31
44.76
Gross Block
400.90
288.00
267.62
57.98
Accumulated Depreciation
44.25
29.96
18.31
13.22
Non Current Assets
433.26
412.66
303.09
135.48
Capital Work in Progress
0.04
0.12
0.07
0.00
Non Current Investment
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
9.95
117.59
5.14
71.89
Other Non Current Assets
0.03
0.03
0.03
0.02
Current Assets
690.11
453.92
324.64
234.45
Current Investments
0.00
0.00
0.00
0.00
Inventories
199.64
125.05
89.40
57.11
Sundry Debtors
350.34
258.74
187.49
134.54
Cash & Bank
5.79
24.27
22.64
20.79
Other Current Assets
134.34
0.65
0.22
0.12
Short Term Loans & Adv.
133.54
45.21
24.88
21.89
Net Current Assets
142.65
109.57
56.94
77.93
Total Assets
1,123.37
866.58
627.73
369.93

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
-65.08
12.87
6.02
12.10
PBT
89.05
68.00
40.26
22.77
Adjustment
87.99
69.02
29.38
18.63
Changes in Working Capital
-235.25
-109.82
-57.52
-22.26
Cash after chg. in Working capital
-58.21
27.20
12.12
19.14
Interest Paid
0.00
0.00
0.00
0.00
Tax Paid
-6.87
-14.33
-6.10
-7.04
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
Cash From Investing Activity
-24.64
-121.97
-158.20
-61.87
Net Fixed Assets
-112.25
-19.72
-200.16
Net Investments
-3.48
0.00
-2.55
Others
91.09
-102.25
44.51
Cash from Financing Activity
71.24
110.73
153.11
55.48
Net Cash Inflow / Outflow
-18.48
1.62
0.93
5.71
Opening Cash & Equivalents
24.27
22.64
20.79
15.08
Closing Cash & Equivalent
5.79
24.27
22.64
20.79

Financial Ratios

Standalone /

Consolidated
Description
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
40.47
36.22
28.39
25.21
ROA
6.07%
6.02%
4.35%
4.57%
ROE
26.81%
28.86%
16.79%
13.90%
ROCE
20.48%
20.90%
17.03%
12.83%
Fixed Asset Turnover
2.96
2.69
2.99
6.50
Receivable days
109.13
109.12
120.65
130.26
Inventory Days
58.18
52.44
54.89
55.29
Payable days
34.94
33.09
37.32
46.77
Cash Conversion Cycle
132.36
128.48
138.22
138.79
Total Debt/Equity
2.33
3.03
2.71
1.51
Interest Cover
2.13
2.13
2.39
2.39

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.